EBITDA: Income before interest, taxes, depreciation and amortization.
Zevra Therapeutics, Inc. (ZVRA) had EBITDA of $3.32M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$26.06M |
|
$-0.54M |
|
$1.24M |
|
$24.82M |
|
$21.92M |
|
$4.14M |
|
$-5.12M |
|
$-0.98M |
|
$-0.98M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$4.14M |
|
|
EBITDA |
$3.32M |
55.95M |
|
55.95M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$225.12M |
|
$0.49M |
|
$45.00M |
|
$270.12M |
|
$26.11M |
|
$61.31M |
|
$110.84M |
|
$136.95M |
|
$133.16M |
|
$121.73M |
|
$133.16M |
|
55.25M |
|
| Cash Flow Statement Financials | |
$-7.11M |
|
$17.90M |
|
$9.52M |
|
$33.78M |
|
$54.44M |
|
$20.65M |
|
$8.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.62 |
|
-- |
|
-- |
|
0.32 |
|
0.46 |
|
95.25% |
|
15.90% |
|
15.90% |
|
-- |
|
-3.75% |
|
-2.09% |
|
$-7.39M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.91 |
|
1.55 |
|
58.15 |
|
-0.41% |
|
-0.45% |
|
-0.20% |
|
-0.28% |
|
$2.41 |
|
$-0.13 |
|
$-0.13 |
|